Fresenius Medical Net Income Over Time
| FMS Stock | USD 22.70 0.18 0.80% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Fresenius Medical Performance and Fresenius Medical Correlation. Fresenius | Build AI portfolio with Fresenius Stock |
Is there potential for Health Care Providers & Services market expansion? Will Fresenius introduce new products? Factors like these will boost the valuation of Fresenius Medical. Market participants price Fresenius higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.295 | Dividend Share 1.44 | Earnings Share 1.47 | Revenue Per Share | Quarterly Revenue Growth 0.026 |
Fresenius Medical Care's market price often diverges from its book value, the accounting figure shown on Fresenius's balance sheet. Smart investors calculate Fresenius Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Fresenius Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Fresenius Medical Care and related stocks such as Universal Health Services, Tenet Healthcare, and Encompass Health Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UHS | 21.7 M | 398.2 M | 443.4 M | 510.7 M | 545.3 M | 680.5 M | 702.4 M | 752.3 M | 779.7 M | 814.9 M | 944 M | 991.6 M | 675.6 M | 717.8 M | 1.1 B | 1.3 B | 1.4 B |
| THC | 63 M | 82 M | 152 M | (134 M) | 12 M | (140 M) | (192 M) | (704 M) | 104 M | (215 M) | 399 M | 914 M | 411 M | 611 M | 3.2 B | 3.7 B | 3.9 B |
| EHC | (1.5 M) | 208.7 M | 185 M | 323.6 M | 222 M | 183.1 M | 247.6 M | 271.1 M | 292.3 M | 358.7 M | 284.2 M | 412.2 M | 271 M | 352 M | 455.7 M | 524.1 M | 550.3 M |
| DVA | 4.9 M | 478 M | 536 M | 633.4 M | 723.1 M | 269.7 M | 879.9 M | 663.6 M | 159.4 M | 811 M | 773.6 M | 978.5 M | 560.4 M | 691.5 M | 936.3 M | 1.1 B | 1.1 B |
| SNN | 68.4 M | 582 M | 729 M | 556 M | 501 M | 410 M | 784 M | 767 M | 663 M | 600 M | 448 M | 524 M | 223 M | 263 M | 412 M | 473.8 M | 371.1 M |
| RPRX | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | 581.4 M | 565.9 M | 1.2 B | 1.4 B | 2.3 B | 975 M | 619.7 M | 42.8 M | 1.1 B | 859 M | 987.8 M | 968.3 M |
| HOLX | 1.4 M | (73.6 M) | (1.2 B) | 17.3 M | 131.6 M | 330.8 M | 755.5 M | (111.3 M) | (40.2 M) | 1.1 B | 1.9 B | 1.3 B | 456 M | 789.5 M | 565.7 M | 650.6 M | 683.1 M |
| SOLV | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.5 B | 1.3 B | 1.3 B | 479 M | 431.1 M | 409.5 M |
| TEM | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (115 M) | (209.9 M) | (259.2 M) | (289.8 M) | (214.1 M) | (705.8 M) | (635.2 M) | (603.5 M) |
| ICLR | 3.9 M | 22.9 M | 55.4 M | 102.8 M | 172.5 M | 239.5 M | 262.2 M | 281.5 M | 322.8 M | 374 M | 327.8 M | 153.2 M | 505.3 M | 612.3 M | 791.5 M | 910.2 M | 955.7 M |
Fresenius Medical Care and related stocks such as Universal Health Services, Tenet Healthcare, and Encompass Health Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Fresenius Medical Care financial statement analysis. It represents the amount of money remaining after all of Fresenius Medical Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Fresenius Medical Care | FMS |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Else-Krner-Strasse 1, Bad |
| Exchange | New York Stock Exchange |
USD 22.7
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.